These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12889158)

  • 21. Association between blood carisoprodol:meprobamate concentration ratios and CYP2C19 genotype in carisoprodol-drugged drivers: decreased metabolic capacity in heterozygous CYP2C19*1/CYP2C19*2 subjects?
    Bramness JG; Skurtveit S; Fauske L; Grung M; Molven A; Mørland J; Steen VM
    Pharmacogenetics; 2003 Jul; 13(7):383-8. PubMed ID: 12835613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of voriconazole and cytochrome P450 2C19 genetic status.
    Ikeda Y; Umemura K; Kondo K; Sekiguchi K; Miyoshi S; Nakashima M
    Clin Pharmacol Ther; 2004 Jun; 75(6):587-8. PubMed ID: 15179414
    [No Abstract]   [Full Text] [Related]  

  • 24. Helicobacter pylori eradication, CYP2C19 and omeprazole doses.
    Manes G
    Aliment Pharmacol Ther; 2005 Aug; 22(3):273-4; author reply 274. PubMed ID: 16091066
    [No Abstract]   [Full Text] [Related]  

  • 25. Rabeprazole experience in Korea; focus on CYP2C19 polymorphism.
    Park SH
    J Gastroenterol Hepatol; 2005 Dec; 20 Suppl():S20-1. PubMed ID: 16359345
    [No Abstract]   [Full Text] [Related]  

  • 26. High frequencies of CYP2C19 mutations and poor metabolism of proguanil in Vanuatu.
    Kaneko A; Kaneko O; Taleo G; Björkman A; Kobayakawa T
    Lancet; 1997 Mar; 349(9056):921-2. PubMed ID: 9093256
    [No Abstract]   [Full Text] [Related]  

  • 27. Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection.
    Sugimoto M; Furuta T; Shirai N; Nakamura A; Kajimura M; Sugimura H; Hishida A; Ishizaki T
    Aliment Pharmacol Ther; 2005 Nov; 22(10):1033-40. PubMed ID: 16268979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The molecular mechanism of polymorphism of S-mephenytoin hydroxylative metabolism].
    Lou YQ; Kuang TY
    Sheng Li Ke Xue Jin Zhan; 1995 Jan; 26(1):23-8. PubMed ID: 7604218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The crucial role of the therapeutic window in understanding the clinical relevance of the poor versus the ultrarapid metabolizer phenotypes in subjects taking drugs metabolized by CYP2D6 or CYP2C19.
    de Leon J
    J Clin Psychopharmacol; 2007 Jun; 27(3):241-5. PubMed ID: 17502769
    [No Abstract]   [Full Text] [Related]  

  • 30. [Advances in the study of pharmacogenetics in China in 1996].
    Xie H; Zhou H
    Zhonghua Yi Xue Za Zhi; 1997 Jan; 77(1):77-8. PubMed ID: 9596985
    [No Abstract]   [Full Text] [Related]  

  • 31. Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection.
    Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Inaba T; Yamamoto K; Okada H; Yokota K; Oguma K; Shiratori Y
    Am J Gastroenterol; 2003 Nov; 98(11):2403-8. PubMed ID: 14638340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotyping and haplotyping of CYP2C19 functional alleles on thin-film biosensor chips.
    Nakamoto K; Kidd JR; Jenison RD; Klaassen CD; Wan YJ; Kidd KK; Zhong XB
    Pharmacogenet Genomics; 2007 Feb; 17(2):103-14. PubMed ID: 17301690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population.
    Zand N; Tajik N; Moghaddam AS; Milanian I
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):102-5. PubMed ID: 17201743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A major influence of CYP2C19 genotype on the steady-state concentration of N-desmethylclobazam.
    Kosaki K; Tamura K; Sato R; Samejima H; Tanigawara Y; Takahashi T
    Brain Dev; 2004 Dec; 26(8):530-4. PubMed ID: 15533655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethnic and geographical distributions of CYP2C19 alleles in the populations of Southeast Asia.
    Yusuf I; Djojosubroto MW; Ikawati R; Lum K; Kaneko A; Marzuki S
    Adv Exp Med Biol; 2003; 531():37-46. PubMed ID: 12916779
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori.
    Furuta T; Sugimoto M; Shirai N; Matsushita F; Nakajima H; Kumagai J; Senoo K; Kodaira C; Nishino M; Yamade M; Ikuma M; Watanabe H; Umemura K; Ishizaki T; Hishida A
    Aliment Pharmacol Ther; 2007 Sep; 26(5):693-703. PubMed ID: 17697203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CYP2C19 genotype and S-mephenytoin 4'-hydroxylation phenotype in a Chinese Dai population.
    He N; Yan FX; Huang SL; Wang W; Xiao ZS; Liu ZQ; Zhou HH
    Eur J Clin Pharmacol; 2002 Apr; 58(1):15-8. PubMed ID: 11956668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allelic variants of drug metabolizing enzymes as risk factors in psoriasis.
    Richter-Hintz D; Their R; Steinwachs S; Kronenberg S; Fritsche E; Sachs B; Wulferink M; Tonn T; Esser C
    J Invest Dermatol; 2003 May; 120(5):765-70. PubMed ID: 12713578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of cytochrome P450 2C19 genetic polymorphism and dosage of rabeprazole on accuracy of proton-pump inhibitor testing in Chinese patients with gastroesophageal reflux disease.
    Lee YC; Lin JT; Wang HP; Chiu HM; Wu MS
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1286-92. PubMed ID: 17559380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochrome P450 polymorphism as a predictor of ovarian toxicity to pulse cyclophosphamide in systemic lupus erythematosus.
    Singh G; Saxena N; Aggarwal A; Misra R
    J Rheumatol; 2007 Apr; 34(4):731-3. PubMed ID: 17407229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.